Psychopharmacology

, Volume 105, Issue 1, pp 9–12 | Cite as

Potentiation of pentazocine conditioned place preference by tripelennamine in rats

  • Tsutomu Suzuki
  • Yoshikazu Masukawa
  • Yoshinao Shiozaki
  • Miwa Misawa
Original Investigations

Abstract

The effects of tripelennamine on place preference conditioning in rats with pentazocine were investigated. Pentazocine at a dose of 2 mg/kg (IP) slightly, but not significantly, induced a place preference. Concurrent dosing of pentazocine (2 mg/kg, IP) and tripelennamine (2.5 mg/kg, SC) significantly and prominently produced a place preference, although administration of tripelennamine (2.5 mg/kg, SC) alone did not. Chronic infusion of a dopamine D1 receptor antagonist, SCH23390 (1.0 mg/kg/day) during conditioning abolished the appetitive effect of pentazocine potentiated by the combination with tripelennamine. In conclusion, it is suggested that the dopaminergic system, especially at the D1 receptor, plays an important role in the potentiation effect of tripelennamine on the pentazocine-induced place preference.

Key words

Pentazocine Tripelennamine SCH23390 Place preference Potentiation Dopamine D1 receptor Rat 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bergman J, Spealman RD (1986) Some behavioral effects of histamine H1 antagonists in squirrel monkeys. J Pharmacol Exp Ther 239:104–110PubMedGoogle Scholar
  2. Butch AJ, Yokel RA, Sigell LT, Hanenson IB, Nelson ED (1979) Abuse and pulmonary complications of injecting pentazocine and tripelennamine tablets. Clin Toxicol 14:301–306PubMedGoogle Scholar
  3. Evans SM, Johanson CE (1989) Discriminative stimulus properties of histamine H1-antagonists in animals trained to discriminate d-amphetamine or pentobarbital. J Pharmacol Exp Ther 250:779–786PubMedGoogle Scholar
  4. Lange WR, Jasinski DR (1984) The clinical pharmacology of pentazocine and tripelennamine (T's and blues). Problems of drug dependence. Adv Alcohol Subst Abuse 5:71–83Google Scholar
  5. Lahmeyer HW, Steingold RG (1980) Pentazocine and tripelennamine: a drug abuse epidemic? Int J Addict 15:1219–1232PubMedGoogle Scholar
  6. Mucha RF, Herz A (1985) Motivational properties of kappa and mu-opioid receptor agonists studied with place and taste preference conditioning. Psychopharmacology 86:274–280PubMedGoogle Scholar
  7. Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preference: a procedural examination. Psychopharmacology 82:241–247CrossRefPubMedGoogle Scholar
  8. Poklis A, Mackell MA (1982) Pentazocine and tripelennamine (T's and blues) abuse: toxicological finding in 39 cases. J Anal Toxicol 6:109–114PubMedGoogle Scholar
  9. Poklis A, Whyatt PL (1980) Current trends in the abuse of pentazocine and tripelennamine; the metropolitan St. Louis experience. J Forensic Sci 25:72–78PubMedGoogle Scholar
  10. Shippenberg TS, Herz A (1987) Place preference conditioning reveals the involvement of D1-dopamine receptors in the motivational properties of μ- and κ-opioid agonists. Brain Res 436:169–172PubMedGoogle Scholar
  11. Showalter CV (1980) T's and Blues-Abuse of pentazocine and tripelennamine. JAMA 224:1224–1225Google Scholar
  12. Showalter CV, Moore L (1978) Abuse of pentazocine and tripelennamine. JAMA 239:1610–1612Google Scholar
  13. Suzuki T, Masukawa Y, Misawa M (1990) Drug interactions in the reinforcing effects of over-the-counter cough syrups. Psychopharmacology 102:438–442CrossRefPubMedGoogle Scholar
  14. Tagashira E, Kachur JF, Carter WH Jr, Dewey WL (1984) Pentazocine-tripelennamine (“T's and Blues”) substitution studies in morphine-dependent rodents. J Pharmacol Exp Ther 231:97–101PubMedGoogle Scholar
  15. Yeh SY (1985) Potentiation of pentazocine analgesia by tripelennamine in the rat. J Pharmacol Exp Ther 235:683–689PubMedGoogle Scholar
  16. Yeh SY, Todd GD, Jonson RE, Gorodetzky CW, Lange WR (1986) The pharmacokinetics of pentazocine and tripelennamine. Clin Pharmacol Ther 39:669–676PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • Tsutomu Suzuki
    • 1
  • Yoshikazu Masukawa
    • 1
    • 2
  • Yoshinao Shiozaki
    • 1
  • Miwa Misawa
    • 1
  1. 1.Department of Applied Pharmacology, School of PharmacyHoshi UniversityTokyoJapan
  2. 2.Department of PharmacologyBiological Research Laboratories, Lederle (Japan), LtdSaitamaJapan

Personalised recommendations